Bidirectional associations and common inflammatory biomarkers in COVID-19 and mental health disorders: A window of opportunity for future research?
Main Author: | Hugo Senra |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354621000405 |
Similar Items
-
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
by: Maria S. Simon, et al.
Published: (2021-09-01) -
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-04-01) -
Biomarkers of Post-COVID Depression
by: Piotr Lorkiewicz, et al.
Published: (2021-09-01) -
Molecular Biomarkers for Pediatric Depressive Disorders: A Narrative Review
by: Jongha Lee, et al.
Published: (2021-09-01) -
Protein Levels of Pro-Inflammatory Cytokines and Chemokines as Biomarkers of Mycobacterium bovis Infection and BCG Vaccination in Cattle
by: Connelley, T.K, et al.
Published: (2022)